Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In

Hematology/Oncology

CME

To B12 or Not to B12

Homocysteine lowering therapy appears to have beneficial effect.
CME credit is no longer available for this conference.

Course Authors

Robert G. Lerner, M.D.

In the past three years, Dr. Lerner has been a speaker for Aventis, Novo Nordisk and Pharmacia.

Estimated course time: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 
Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • Discuss the controversy about vitamin B12 and folate dietary supplementation and knowledgeably prescribe appropriately

  • Interpret laboratory reports of vitamin B12 and homocysteine blood levels

  • Appreciate defects of vitamin B12 absorption other than classic pernicious anemia.

 

TERMS AND CONDITIONS

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity

Courses You Might Like

AML2

Estimated Time: 6 Hours
View Course
More

Emerging Treatments In Acute Myeloid Leukemia (AML)

Several investigational agents offer hope to patients with AML.
Authors: Mary-Elizabeth M. Percival, M.D., M.S. and Roland B. Walter, M.D., Ph.D., M.S.
Estimated Time: 1 Hour
View Course
More

Pro-State Challenge 2

Estimated Time: 6 Hours
View Course
More

Unexplained Bleeding in Hospitalized Patients

While some disorders are more readily apparent than others, not all bleeding is straightforward or has a readily identifiable cause.
Authors: Meera B. Chitlur, M.D.
Estimated Time: 1 Hour
View Course
More

Lung Cancer Chemoprevention

Despite advances in lung cancer chemotherapy, there is a pressing need for effective lung cancer chemoprevention beyond smoking cessation.
Authors: Robert L. Keith, M.D.
Estimated Time: 1 Hour
View Course
More

Molecularly Targeted Therapy for Malignant Brain Tumors

Neuro−oncology is focusing on the uses of molecularly targeted agents in the adjuvant setting.
Authors: Nicole A. Shonka, M.D., and Mark R. Gilbert, M.D.
Estimated Time: 1 Hour
View Course
More